Literature DB >> 34285972

Virucidal and Neutralizing Activity Tests for Antiviral Substances and Antibodies.

Chie Aoki-Utsubo1, Ming Chen2, Hak Hotta1,2,3.   

Abstract

In a narrow definition, virucidal activity represents the activity by which to interact with and physically disrupt viral particles. In a broad definition, it includes the activity by which to functionally inhibit (neutralize) viral infectivity without apparent morphological alterations of the viral particles. The viral infectivity can be measured in cell culture system by means of plaque assay, infectious focus assay, 50% tissue culture infectious dose (TCID50) assay, etc. Morphologically, disruption of viral particles can be demonstrated by negative staining electron microscopic analysis of viral particles. In this article, we describe methods to assess virucidal activity in a broad definition.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Antibody; Antiviral substance; Negative staining electron microscopic analysis; Neutralizing activity; Viral infectivity assay; Viral particle; Virucidal activity

Year:  2018        PMID: 34285972      PMCID: PMC8275317          DOI: 10.21769/BioProtoc.2855

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  11 in total

1.  Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.

Authors:  T Hayashi; H Hotta; M Itoh; M Homma
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

2.  An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses.

Authors:  David J Holthausen; Song Hee Lee; Vineeth Tv Kumar; Nicole M Bouvier; Florian Krammer; Ali H Ellebedy; Jens Wrammert; Anice C Lowen; Sanil George; Madhavan Radhakrishna Pillai; Joshy Jacob
Journal:  Immunity       Date:  2017-04-18       Impact factor: 31.745

Review 3.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

Authors:  Troels K H Scheel; Charles M Rice
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Herpes simplex virus type 1-induced hydrocephalus in mice.

Authors:  K Hayashi; Y Iwasaki; K Yanagi
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Inhibition of transcriptase activity of influenza A virus in vitro by anti-haemagglutinin antibodies.

Authors:  K Shimizu; J Mukaigawa; M Oguro; Y Ono; K Nakajima; H Kida
Journal:  Vaccine       Date:  1985-09       Impact factor: 3.641

6.  Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.

Authors:  Dadan Ramadhan Apriyanto; Chie Aoki; Sri Hartati; Muhammad Hanafi; Leonardus Broto Sugeng Kardono; Ade Arsianti; Melva Louisa; Tjahjani Mirawati Sudiro; Beti Ernawati Dewi; Pratiwi Sudarmono; Amin Soebandrio; Hak Hotta
Journal:  Jpn J Infect Dis       Date:  2015-08-07       Impact factor: 1.362

7.  Antibody-mediated enhancement of dengue virus infection in mouse macrophage cell lines, Mk1 and Mm1.

Authors:  H Hotta; A S Wiharta; S Hotta
Journal:  Proc Soc Exp Biol Med       Date:  1984-03

8.  Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.

Authors:  Yasuaki Bungyoku; Ikuo Shoji; Tatsuhiko Makine; Tetsuya Adachi; Kazumi Hayashida; Motoko Nagano-Fujii; Yoshi-Hiro Ide; Lin Deng; Hak Hotta
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

9.  Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.

Authors:  Ming Chen; Chie Aoki-Utsubo; Masanori Kameoka; Lin Deng; Yutaka Terada; Wataru Kamitani; Kei Sato; Yoshio Koyanagi; Makoto Hijikata; Keiko Shindo; Takeshi Noda; Michinori Kohara; Hak Hotta
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

10.  Isolation of human monoclonal antibodies to the envelope e2 protein of hepatitis C virus and their characterization.

Authors:  Yohko K Shimizu; Minako Hijikata; Masamichi Oshima; Kazufumi Shimizu; Harvey J Alter; Robert H Purcell; Hiroshi Yoshikura; Hak Hotta
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.